Cargando…

Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection

BACKGROUND: Nucleofection is an emerging technology for delivery of nucleic acids into both the cytoplasm and nucleus of eukaryotic cells with high efficiency. This makes it an ideal technology for gene delivery and siRNA applications. A 96-well format has recently been made available for high-throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradburne, Christopher, Robertson, Kelly, Thach, Dzung
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683797/
https://www.ncbi.nlm.nih.gov/pubmed/19432988
http://dx.doi.org/10.1186/1479-0556-7-6
_version_ 1782167134488494080
author Bradburne, Christopher
Robertson, Kelly
Thach, Dzung
author_facet Bradburne, Christopher
Robertson, Kelly
Thach, Dzung
author_sort Bradburne, Christopher
collection PubMed
description BACKGROUND: Nucleofection is an emerging technology for delivery of nucleic acids into both the cytoplasm and nucleus of eukaryotic cells with high efficiency. This makes it an ideal technology for gene delivery and siRNA applications. A 96-well format has recently been made available for high-throughput nucleofection, however conditions must be optimized for delivery into each specific cell type. Screening each 96-well plate can be expensive, and descriptions of methods and outcomes to determine the best conditions are lacking in the literature. Here we employ simple methods, including cell counting, microscopy, viability and cytotoxicity assays to describe the minimal experimental methods required to optimize nucleofection conditions for a given cell line. METHODS: We comprehensively measured and analyzed the outcomes of the 96-well nucleofection of pmaxGFP plasmids encoding green fluorescent protein (GFP) into the A-549 human lung epithelial cell line. Fluorescent microscopy and a plate reader were used to respectively observe and quantify green fluorescence in both whole and lysed cells. Cell viability was determined by direct counting/permeability assays, and by both absorbance and fluorescence-based plate reader cytotoxicity assays. Finally, an optimal nucleofection condition was used to deliver siRNA and gene specific knock-down was demonstrated. RESULTS: GFP fluorescence among conditions ranged from non-existent to bright, based upon the fluorescent microscopy and plate reader results. Correlation between direct counting of cells and plate-based cytotoxicity assays were from R = .81 to R = .88, depending on the assay. Correlation between the GFP fluorescence of lysed and unlysed cells was high, ranging from R = .91 to R = .97. Finally, delivery of a pooled sample of siRNAs targeting the gene relA using an optimized nucleofection condition resulted in a 70–95% knock down of the gene over 48 h with 90–97% cell viability. CONCLUSION: Our results show the optimal 96-well nucleofection conditions for the widely-used human cell line, A-549. We describe simple, effective methods for determining optimal conditions with high confidence, providing a useful road map for other laboratories planning optimization of specific cell lines or primary cells. Our analysis of outcomes suggests the need to only measure unlysed, whole-cell fluorescence and cell metabolic activity using a plate reader cytotoxicity assay to determine the best conditions for 96-well nucleofection.
format Text
id pubmed-2683797
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26837972009-05-19 Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection Bradburne, Christopher Robertson, Kelly Thach, Dzung Genet Vaccines Ther Methodology BACKGROUND: Nucleofection is an emerging technology for delivery of nucleic acids into both the cytoplasm and nucleus of eukaryotic cells with high efficiency. This makes it an ideal technology for gene delivery and siRNA applications. A 96-well format has recently been made available for high-throughput nucleofection, however conditions must be optimized for delivery into each specific cell type. Screening each 96-well plate can be expensive, and descriptions of methods and outcomes to determine the best conditions are lacking in the literature. Here we employ simple methods, including cell counting, microscopy, viability and cytotoxicity assays to describe the minimal experimental methods required to optimize nucleofection conditions for a given cell line. METHODS: We comprehensively measured and analyzed the outcomes of the 96-well nucleofection of pmaxGFP plasmids encoding green fluorescent protein (GFP) into the A-549 human lung epithelial cell line. Fluorescent microscopy and a plate reader were used to respectively observe and quantify green fluorescence in both whole and lysed cells. Cell viability was determined by direct counting/permeability assays, and by both absorbance and fluorescence-based plate reader cytotoxicity assays. Finally, an optimal nucleofection condition was used to deliver siRNA and gene specific knock-down was demonstrated. RESULTS: GFP fluorescence among conditions ranged from non-existent to bright, based upon the fluorescent microscopy and plate reader results. Correlation between direct counting of cells and plate-based cytotoxicity assays were from R = .81 to R = .88, depending on the assay. Correlation between the GFP fluorescence of lysed and unlysed cells was high, ranging from R = .91 to R = .97. Finally, delivery of a pooled sample of siRNAs targeting the gene relA using an optimized nucleofection condition resulted in a 70–95% knock down of the gene over 48 h with 90–97% cell viability. CONCLUSION: Our results show the optimal 96-well nucleofection conditions for the widely-used human cell line, A-549. We describe simple, effective methods for determining optimal conditions with high confidence, providing a useful road map for other laboratories planning optimization of specific cell lines or primary cells. Our analysis of outcomes suggests the need to only measure unlysed, whole-cell fluorescence and cell metabolic activity using a plate reader cytotoxicity assay to determine the best conditions for 96-well nucleofection. BioMed Central 2009-05-11 /pmc/articles/PMC2683797/ /pubmed/19432988 http://dx.doi.org/10.1186/1479-0556-7-6 Text en Copyright © 2009 Bradburne et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Bradburne, Christopher
Robertson, Kelly
Thach, Dzung
Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title_full Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title_fullStr Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title_full_unstemmed Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title_short Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
title_sort assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683797/
https://www.ncbi.nlm.nih.gov/pubmed/19432988
http://dx.doi.org/10.1186/1479-0556-7-6
work_keys_str_mv AT bradburnechristopher assessmentofmethodsandanalysisofoutcomesforcomprehensiveoptimizationofnucleofection
AT robertsonkelly assessmentofmethodsandanalysisofoutcomesforcomprehensiveoptimizationofnucleofection
AT thachdzung assessmentofmethodsandanalysisofoutcomesforcomprehensiveoptimizationofnucleofection